Jill Stein’s Third-Party Candidacy
Readers discuss Democrats’ concerns that her bid will throw the election to Donald Trump. Also: Harris ads; drug-free treatments; regretting email.
U.S. Study on Puberty Blockers Goes Unpublished Because of Politics, Doctor Says
The leader of the long-running study said that the drugs did not improve mental health in children with gender distress and that the finding might be weaponized by opponents of the care.
What Drugmakers Did Not Tell Volunteers in Alzheimer’s Trials
Genetic tests showed that certain patients were predisposed to brain injuries if they took the drugs. That information remained secret.
Biden Mocks Trump’s ‘Concept of a Plan’ to Replace Obamacare
During a visit to New Hampshire to discuss the cost of prescription drugs, President Biden warned that a second Trump presidency could lead millions of people to lose health care.
Biden to Propose That Insurers Cover Over-the-Counter Birth Control
The new rules under the Affordable Care Act would include emergency contraception, a newly approved nonprescription birth control pill, spermicides and condoms.
States Revive Lawsuit to Sharply Curb Access to Abortion Pill
The Supreme Court ruled in June that the original plaintiffs, anti-abortion doctors and groups, did not have standing to sue. Now three states are trying to continue the legal fight.
Sammy Basso, Advocate for Progeria Research, Is Dead at 28
One of about 150 people known to have a rare condition that causes rapid aging, he sought to raise awareness and participated in the search for a cure.
In L.A., Street Psychiatrists Offer the Homeless a Radical Step Forward
The crisis of homelessness is pushing American psychiatry to places it has not gone before — like sidewalk injections of antipsychotics.
CVS Ousts Karen Lynch as C.E.O. and Shares Fall
Shares of the health care conglomerate dropped after the sudden departure of Karen Lynch and a downbeat update on the state of the company’s finances.
Why We May Soon Use Ozempic to Treat Addiction
Early data suggests GLP-1 drugs, renowned for their ability to assist in weight loss, may have a powerful effect on treating addiction.
Call for more information
888-531-0245
info@siii-clinical.com
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.